- Home
- SERA vs GDL Comparison
SERA vs GDL Comparison
Compare SERA & GDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SERA | GDL |
|---|---|---|
| Founded | 2008 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.2M | 90.1M |
| IPO Year | 2021 | 2006 |
Fundamental Metrics
Financial Performance| Metric | SERA | GDL |
|---|---|---|
| Price | $2.06 | $8.41 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $5.50 | N/A |
| AVG Volume (30 Days) | ★ 16.1K | 12.4K |
| Earning Date | 11-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.02% |
| EPS Growth | ★ 32.32 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $81,000.00 | N/A |
| Revenue This Year | $177.78 | N/A |
| Revenue Next Year | $755.56 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 5.19 | N/A |
| 52 Week Low | $1.56 | $8.01 |
| 52 Week High | $3.95 | $8.67 |
Technical Indicators
Market Signals| Indicator | SERA | GDL |
|---|---|---|
| Relative Strength Index (RSI) | 50.86 | 58.43 |
| Support Level | $1.96 | $8.36 |
| Resistance Level | $2.07 | $8.51 |
| Average True Range (ATR) | 0.09 | 0.07 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 28.57 | 83.33 |
Price Performance
Historical ComparisonAbout SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
About GDL GDL Fund The of Beneficial Interest
GDL Fund is a diversified closed-end management investment company. Its primary investment objective is to achieve absolute returns in various market conditions without excessive risk of capital. The fund seeks to achieve its objective by investing in merger arbitrage transactions and, to a lesser extent, in corporate reorganizations involving stubs, spin-offs, and liquidations.